June E. Nylen Cancer Center’s Benefit a Success
The June E. Nylen Cancer Center’s 16th Annual Winter Benefit held at Bev's Hilton Garden Inn Saturday, February 22 raised nearly $138,000 with 300+ people attending. Community volunteers Tom Baurichter and Virginia Anderson co-chaired the event.
“The money raised this year will help purchase new radiation technology. Community support from our sponsors and many other donors in the past several years have helped us make dramatic advances in cancer treatment at the Nylen Cancer Center,” says Karen Van De Steeg, executive director. “VisionRT is an optical guidance system that is used with stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) procedures."
Carrying a theme of “Cupcakes and Snowflakes" the event featured a live and silent auction, a beer and wine tasting with entertainment provided by Mitch Martin and Emily Johnson. Bruce Miller of the Sioux City Journal served as master of ceremonies and Clint Voss was the auctioneer.
Premier sponsors for the cancer center fundraiser were Apex Tackle/Maurice Sporting Goods, Mike and Margie Bennett and Jan and Charles Wolterman. Other top sponsors were FIMCO, Dr. and Mrs. Ryan Meis, L.P. Gill, Ignite Sunless Tanning, Midlands Clinic, Mr. & Mrs. Paul Winchell and Wireless World- Verizon and the family of David Leo Carlson.
“This year Dr. Charles Murphy and Dr. Kamalesh Bala served as honorary co-chairs which helped us raise awareness and community support to benefit local cancer patients,” says Van De Steeg. “One hundred percent of the funds raised stay right here in Siouxland.”
The June E. Nylen Cancer Center is one of only a few freestanding treatment centers of its kind in the Midwest. Using a holistic approach, they offer state-of-the-art treatment, technology, expert care, education information, counseling and support services. Serving patients in 33 counties in the tri-state area with patient visits averaging 175 a day and exceeding over 35,000 a year. The most frequently treated are lung, prostate, breast and colon cancers.